124 related articles for article (PubMed ID: 15686508)
21. Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125.
Allen GW; Forouzannia A; Bailey HH; Howard SP
Gynecol Oncol; 2004 Sep; 94(3):811-3. PubMed ID: 15350377
[TBL] [Abstract][Full Text] [Related]
22. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
[TBL] [Abstract][Full Text] [Related]
23. Possible involvement of neutrophils in a serum level increase of hepatocyte growth factor in non-Hodgkin's lymphoma.
Toyama T; Ido A; Sasak H; Maeda K; Yamashita K; Kubuki Y; Suzuki M; Matsuoka H; Tsubouchi H
Oncol Rep; 2005 Mar; 13(3):439-44. PubMed ID: 15706413
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
25. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
[TBL] [Abstract][Full Text] [Related]
26. Ifosfamide, idarubicin, and etoposide in relapsed/refractory Hodgkin disease or non-Hodgkin lymphoma: a salvage regimen with high response rates before autologous stem cell transplantation.
Oyan B; Koc Y; Ozdemir E; Kars A; Turker A; Tekuzman G; Kansu E
Biol Blood Marrow Transplant; 2005 Sep; 11(9):688-97. PubMed ID: 16125639
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of soluble interleukin-2 receptor in serum of patients with hematological or non-hematological malignancies.
Nakase K; Tsuji K; Tamaki S; Tanigawa M; Ikeda T; Miyanishi E; Shiku H
Cancer Detect Prev; 2005; 29(3):256-9. PubMed ID: 15899555
[TBL] [Abstract][Full Text] [Related]
28. Hematological malignancies in the island of Sardinia, 1974-1993: age and sex distributions and temporal changes in incidence.
Broccia G; Deplano W; Dessalvi P; Giannico B; Luxi G; Chessa E; Murru A
Hematol Oncol; 2004 Sep; 22(3):91-109. PubMed ID: 15991220
[TBL] [Abstract][Full Text] [Related]
29. Tumor M2-PK levels in haematological malignancies.
Oremek GM; Rox S; Mitrou P; Sapoutzis N; Sauer-Eppel H
Anticancer Res; 2003; 23(2A):1135-8. PubMed ID: 12820361
[TBL] [Abstract][Full Text] [Related]
30. Peripheral blood telomerase activity in non-Hodgkin lymphoma.
Onur I; Akman S; Olgun A; Fen T; Kutluay T
Res Commun Mol Pathol Pharmacol; 2003; 113-114():298-306. PubMed ID: 15686128
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietic activities in acute leukemia and in malignant lymphoma with or without bone marrow involvement.
Choi JW; Pai SH
Ann Clin Lab Sci; 2003; 33(4):407-10. PubMed ID: 14584754
[TBL] [Abstract][Full Text] [Related]
32. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
33. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
34. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
[TBL] [Abstract][Full Text] [Related]
35. Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma.
Olawaiye AB; Rauh-Hain JA; Withiam-Leitch M; Rueda B; Goodman A; del Carmen MG
Gynecol Oncol; 2008 Sep; 110(3):293-8. PubMed ID: 18644620
[TBL] [Abstract][Full Text] [Related]
36. Body mass index, abnormal glucose metabolism, and mortality from hematopoietic cancer.
Chiu BC; Gapstur SM; Greenland P; Wang R; Dyer A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2348-54. PubMed ID: 17164355
[TBL] [Abstract][Full Text] [Related]
37. Serum Ca 125 levels in children with acute leukemia and lymphoma.
Birgen D; Ertem U; Duru F; Sahin G; Yüksek N; Bozkurt C; Karacan CD; Aksoy C
Leuk Lymphoma; 2005 Aug; 46(8):1177-81. PubMed ID: 16085559
[TBL] [Abstract][Full Text] [Related]
38. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
[TBL] [Abstract][Full Text] [Related]
39. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor.
Negaard HF; Iversen PO; Østenstad B; Iversen N; Holme PA; Sandset PM
Thromb Haemost; 2008 Jun; 99(6):1040-8. PubMed ID: 18521506
[TBL] [Abstract][Full Text] [Related]
40. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
